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1
What are Reproductive Tract Infections?
Reproductive Tract Infections (RTIs) encompass three main
groups of infection in men and women:
1. Endogenous infections of the female genital tract – such
as candida or bacterial vaginosis.
2. Sexually transmitted infections (STIs) in both men and
women.
3. Iatrogenic infections, acquired, for example, through
unsterile procedures across the cervix, such as insertion of
an intrauterine device, menstrual regulation or termination
of a pregnancy.
There are over 30 identified organisms which can infect the
reproductive tract. The most common organisms are listed in
Box 1. Of the three types of RTIs, it is probably the
endogenous infections (marked with an * in Box 1), which are
the most common infections in women. The sexually
transmitted infections may have the greatest impact on both
individuals (clinically and socially) and health-care systems
dealing with management of infections (due to the cost of
managing complications of the mis- or un-treated infections ).
In addition to the organisms named in Box 1, there are many
others which can be transmitted sexually, but this is not the
usual mode of transmission – Shigella and Entamoeba histolytica
are examples of these.
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There are over
30 identified
organisms which
can infect the
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Box 1
Micro-organisms associated with sexual transmission or with
infection in the reproductive tract
Viruses

Bacteria

Protozoa

Mycoplasmas

Parasites

Fungi

Herpes
simplex
viruses

Chlamydia
trachomatis

Entamoeba
histolytica

Ureaplasma
urealyticum

Sarcoptes
scabiei

Candida
albicans*

Human
papilloma
virus

Neisseria
gonorrhoeae

Trichomonas
vaginalis

Mycoplasma
hominis*

Phthirus
pubis

Molluscum
contagiosum

Gardnerella
vaginalis*

Giardia
lamblia

Hepatitis
viruses

Treponema
pallidum

Cytomegalovirus

Haemophilus
ducreyi

Human
immunodeficiency
viruses

Ureaplasma
urealyticum

Human T
Lymphotrophic
viruses

Points for Programme Managers
Reproductive Tract Infections (RTIs) can be acquired in three ways:
sexually, iatrogenically and from endogenous carriage. Control of each
of these three types of infection will require different programmatic
and strategic approaches.
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2
Epidemiology of RTIs/STIs
2.1 Epidemiology of RTIs/STIs Globally
Data on prevalence and incidence can be compiled both from
published studies and from surveillance systems. In the case of
RTIs/STIs, there is very little data on global incidence (but
more information on prevalence), and longitudinal data from
surveillance systems is limited to countries with an efficient and
widespread system of reporting. As with most other disease
categories, there is very little homogeneity in the published
global prevalence of RTIs/STIs.
It is estimated that globally in 1995 there were approximately
333 million new cases of the 4 major curable STIs (gonorrhoea,
chlamydia, syphilis, and trichomoniasis) in the 15-49 year old
age group. Highest absolute numbers of new cases were found
in the regions of south and south-east Asia, and sub-Saharan
Africa - a reflection of both the global population distribution,
and the higher recorded prevalence estimates for these regions.
Individual regions may acknowledge specific STI problems – for
example, the incidence of new syphilis infections in the former
Soviet Union is reported to be increasing significantly.

2.2 Epidemiology of RTIs/STIs in India
India displays a remarkable level of heterogeneity in all aspects,
and the epidemiology of RTIs/STIs is no exception. Such
diversity is a reflection of the enormous size of the country, of
the “phase” of the STI/HIV epidemic in any one place (rising,
stable or declining), and of the highly variable broader
contextual factors influencing prevalence and incidence rates
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Table 1
Published STI prevalence among men in India
Prevalence ranges (%)
GC

CT

Syphilis

Chancroid
(clinical
diagnosis)

TV

3.4

2.0

0.3

–

–

–

–

6.0

1.4

1.7

15.0

–

–

5.6

–

–

–

0.4

2.1

–

0.8 - 4.4

–

–

–

–

–

–

8.5 25.9

20.0 30.0

12.6 57.0

16.1 - 34.7

–

3.0 - 14.9

4.9 - 14.3

–

2.0 7.4

STD clinic patients
with genital ulcers

–

–

–

33.0

–

–

–

–

–

Patients attending
primary health care

–

–

3.6

–

–

–

–

–

–

–

–

–

–

60.6

–

–

–

–

Study population

HSV
HPV
HbsAg HIV
(clinical (clinical
diagnosis) diagnosis)

Community-based
or convenience
samples
Males aged
15-45 years
Male participants
of a community
education
programme
Transport and
industrial workers
Facility-based
STD clinic
patients

Specific groups
Spouses of females
with candida and
trichomonas

Notes on Tables: GC = Neisseria gonorrhoeae; CT = Chlamydia trachomatis; TV = Trichomonas vaginalis; HSV = Herpes Simplex Virus;
HPV = Human Papilloma Virus; HbsAg = Hepatitis B surface Antigen; HIV = Human Immunodeficiency Virus
Source Table 1& 2: Hawkes S; and Santhya KG; 2001. Diverse Realities: Understanding STIs and HIV in India.
Regional Working Paper No. 15. New Delhi: Population Council
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Table 2
Published STI prevalence among women in India
Prevalence ranges (%)
Chancroid TV
HSV
HPV Cervical HBV HIV
(clinical
(clinical (clinical dysplasia
diagnosis)
diagnosis) diagnosis)

GC

CT

Syphilis

Community-based
Ever/currently
0.0 married women
4.2

0.5 28.7

0.2 - 8.8

–

4.3 27.4

–

11.8

0.3 3.9

5.2

0.2 - 10.5

_

0.8 14.0

_

_

1.3 10.4
4.9 16.5
1.0 5.5

–

–

–

4.0 - 15.4

6.7 - 15.6

–

–

–

–

–

0.5

–

–

0.2 31.3

29.3 43.3
30.0 63.0
4.4 - 5.6

–

0.4 26.0

0.3 25.0

0.6 42.4

–

2.3

Study population

Unmarried &
married women
Facility-based and
convenience samples
STD clinic
patients
Sex Workers
Gynaecological
OPD patients

Antenatal patients

–

3.8%
_
Grade III
dysplasia
_
4.8

9.2%
–
severe
dyskaryosis
5.4%
invasive
carcinoma
–
–

2.0

1.2 13.6
49.9
0.0

1.0 6.2
2.2

–

17.8

–

–

–

1.6 17.6

–

–

–

–

0.1 1.2
–

–

–

–

–

Gynaecological
0.0 patients with
2.6
‘vaginitis’ complaints
Gynaecological
–
patients with cervical
erosion

2.6 12.2
3.0

–

–

–

–

–

Infertility and PID
patients
Acceptors of tubal
ligation

0.5 24.2
0.0 0.2

0.5

–

0.5

–

–

1.6%
moderate
dysplasia
13%
severe
dysplasia
1.8%
malignant
–

0.5 - 7.0

–

0.9

–

–

–

0.1 11.0
0.1 2.2

_

Notes on Tables: GC = Neisseria gonorrhoeae; CT = Chlamydia trachomatis; TV = Trichomonas vaginalis; HSV = Herpes Simplex Virus;
HPV = Human Papilloma Virus; HbsAg = Hepatitis B surface Antigen; HIV = Human Immunodeficiency Virus
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and the ability of the health care system to record and respond
to these rates. In the absence of a fully functioning STI
surveillance system, predictions and estimates are made on the
basis of ad-hoc surveys, often among facility-based or
convenience samples. Tables1 & 2 provide summaries of the
results of published cross-sectional surveys on STI prevalence
in India.

2.3 Epidemiological Diversity in India
It is important to consider reasons contributing to the
epidemiological diversity reported within Indian studies; these
include:
There is often
a lack of
standardisation in
laboratory criteria
used in each
study – this can
influence
prevalence
reported

i. The size of the country. As noted above, in a country as
large as India, there are wide variations influencing the risks
and vulnerabilities of different populations to STIs
(including HIV). Thus, the wide variation in reported
prevalence may be a reflection of the ‘true’ epidemiological
diversity;
ii. Studies are carried out among people with different levels of
risk – some studies focus on people in the ‘general
population’ (often loosely defined), whilst others
concentrate on ‘risk groups’. It is clearly important to know
who is included in survey results, and exact criteria for
inclusion should be clearly defined.
iii. There is often a lack of standardisation in laboratory criteria
used in each study – this can influence prevalence reported.
In the case of syphilis, for example, some studies report all
rapid plasma reagin (RPR – a screening test for syphilis)
positive cases, whilst others report only those confirmed by
Treponema pallidum haemagglutination assay (TPHA).
Diagnosis of other pathogens, such as Chlamydia trachomatis,
shows an even wider variation in methods and standards
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used. In many studies the laboratory methods used are either
inadequately explained or are not detailed at all.
Retaining this critical perspective on the published data is
important for both understanding the current reported figures,
and for designing future research and control programmes.
A close review of the published epidemiology in India highlights
the following points:
!

Data on STI prevalence in men are lacking, especially men
in the ‘general population’. The majority of facility-based
and community-based studies have focused on examining
STI rates in women and even here the data are relatively
patchy and certainly incomplete, given the size of the
population.

!

There are wide variations in both the reported prevalence of
syphilis and diagnostic criteria used. The high prevalence of
syphilis (ranging from <1% to 10% in some communitybased surveys) among women in some parts of the country
is in little doubt (see Table 2 for details). Despite this,
prevention of mother-to-child transmission of syphilis
(through antenatal screening of all pregnant women) is
unevenly implemented throughout the country.

!

Relatively little research has been carried out on the
epidemiology of the viral infections (apart from HIV).
Hepatitis B infection is believed to be mainly transmitted
from mother-to-child or during childhood. Recent studies
have found an average estimated carrier rate of 4% in the
general population, and researchers have recommended
universal immunization of neonates as the appropriate
strategy for India. The prevalence of genital herpes in the
general male and female population has not been explored in
any of the community based studies. In addition, there are
no community-based studies on the prevalence of antibodies
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Cervical cancer
contributes
significantly to the
burden of
morbidity and
mortality in Indian
women

to HSV-2 – an important virus which is believed to be both
a marker of lifetime sexual activity and risk, and possibly
linked to the risk of HIV transmission.
!

Cervical cancer contributes significantly to the burden of
morbidity and mortality in Indian women with an estimated
90,000 new cervical cancer cases arising annually. Despite
this, little data exist either on the prevalence of different
types of cervical dysplasia among women, or on the number
of women (and men) infected with human papilloma virus
(HPV). Only one community-based study among women in
a Delhi slum has reported on the prevalence of HPV
subtypes and prevalence of cervical dysplasia is similarly
little understood.
Points for Programme Managers

India is characterised by epidemiological diversity in terms of STI/
RTI rates. Results from one part of the country cannot necessarily be
extrapolated to other areas. There are, nonetheless, nation-wide data
gaps and nation-wide priorities which can be identified: information
on men is lacking and we have very little information on most of the
viral STIs in both men and women. Screening pregnant women for
syphilis should be implemented nationally; there should be universal
coverage of neonates for hepatitis B immunisation; and other
programme priorities and interventions should be tailored to the local
epidemiology and aetiology.
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Why Aim to Control Reproductive Tract
Infections and Sexually Transmitted
Infections?
The public health importance of RTIs can be seen from a
number of [interlinked] perspectives ranging from their close
association with HIV transmission, through to their economic
consequences for both the infected/affected individuals and the
overall health care system. The public health salience of RTIs
has increased significantly in recent years, in part as more
research highlights the extent of both the diseases and their
complications. Given the prevailing gender disparities in all
fields of life, women in India are and will be disproportionately
affected by the risk of STI transmission. In addition, women are
significantly more susceptible to the non-sexually transmitted
RTIs. Public health programmes need to be cognisant of these
increased risks for women in order to target resources in a
gender-equitable way.
The importance of RTIs is illustrated through the following
perspectives:
Biological
Improved management of STIs can lead to a significant decrease
in HIV incidence. In those parts of India, which are at the
perceived early or middle stages of an HIV epidemic, the
contribution of STI control to curbing the spread of HIV may
be significant.
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Women in India
are and will be
disproportionately
affected by the
risk of STI
transmission

Political

There has been a
programme-level
shift away from
vertical family
planning services
and towards the
provision of
comprehensive
integrated
reproductive
health (RH) care
at all levels of
health sectors

Recommendations from the 1994 United Nations International
Conference on Population and Development (ICPD) stated that:
“All countries should strive to make accessible through the PHC
[primary health care] system, reproductive health to all
individuals of appropriate ages…[this] should include
…treatment of reproductive tract infections; sexually
transmitted diseases and other reproductive health conditions.”
Following the ICPD there has been a great deal of commitment
to move away from demographic targets and towards a broader
focus on human welfare, individual choice and the goals of
gender equality. As a result, there has been a programme-level
shift away from vertical family planning services and towards
the provision of comprehensive integrated reproductive health
(RH) care at all levels of health sectors. The Government of
India, for example, has stated that the principles guiding
reproductive health service delivery are that they should be
‘client centred, demand driven, high quality, integrated services’.
Economic
The importance of RTIs/STIs from a public health perspective
has increased with the recognition that the economic and
logistical consequences for health care systems seeking to
implement effective prevention and care activities for these
infections can be significant. A 1993 report showed that the
burden of STIs in many urban (high prevalence) populations in
low income countries, as measured by disability-adjusted healthy
life years lost, is a substantial fraction of the entire disease
burden of those populations. RTIs are important not just in their
acute presentation, but also because of their associated sequelae
including: chronic pain, tubal scarring, ectopic pregnancy,
infertility, poor outcomes of pregnancy, and associated
morbidities and mortalities in neonates and infants.
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Not only are RTIs/STIs a significant potential drain on public
sector health care resources, they also contribute substantially to
the patterns of health care expenditure at the household level. A
recent survey of 1100 randomly selected households in and
around the city of Udaipur investigated expenditure on
reproductive and child health (RCH) care. RTI services
constituted the top expenditure for households in their purchase
of all types of RCH care. In other words, families surveyed in
Rajasthan spent more of their own money on seeking care for
symptoms of RTIs than they spent on child health care, and all
forms of safe motherhood (pre- and post-natal, obstetric and
abortion services).
Points for Programme Managers
RTIs are important from a number of perspectives, not least of which
is their salient position on public health agendas – arising in part from
their association with increased HIV transmission. In addition, they have
important economic consequences for public health systems and
individual sufferers.
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Clinical Presentation of RTIs
As with most clinical symptoms and signs, RTIs can present in a
variety of ways. Nonetheless, there are some presentations
which are found more commonly, and these are shown in Box 2.
These have been grouped into seven main syndromes – the
importance of this classification is detailed on page 19.

4.1 Main Clinical Complications of RTIs

RTIs are important
from a number of
public health
perspectives:
economic,
biological, and
political

As detailed above, RTIs are important from a number of public
health perspectives: economic, biological, and political. Much of
the importance of RTIs arises as a result of the complications
and sequelae of mis- or un-treated infections. These
complications include:
!

!

!

Problems in pregnancy - foetal wastage, premature births,
congenital infections; ectopic pregnancy (life-threatening in
some women)
Problems in neonates and infants – blindness, pneumonia,
congenital syphilis
Problems in infected sexually active men and women –
chronic pain, lifelong infection, infertility, neoplasias (genital
cancers, Kaposis sarcoma, liver cancer), increased
transmission of HIV.
Points for Programme Managers

There are over 30 types of organisms which can either infect the
reproductive tract and/or can be transmitted sexually. Most of these
organisms have the potential for serious complications in the individual
sufferer – including transmission during pregnancy or at birth resulting
in neonatal death or illness.
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Box 2
Aetiological agents causing common syndromes in the
reproductive tract
Vaginal
discharge

Genital ulcer Lower
disease
abdominal
pain

Urethral
discharge

Scrotal
swelling

Inguinal
bubo

Chlamydia
trachomatis

Treponema
pallidum
(syphilis)

Chlamydia
trachomatis

Chlamydia
trachomatis

Chlamydia
trachomatis

Chlamydia Human
trachomatis Papilloma
(lympho- Virus
granuloma
venereum)

Neisseria
gonorrhoeae

Haemophilus
ducreyi

Neisseria
gonorrhoeae

Neisseria
gonorrhoeae

Neisseria
gonorrhoeae

Trichomonas
vaginalis

Herpes
simplex
Viruses

Organisms
of bacterial
vaginosis

Candida

Calymmatobacterium
granulomatis
(donovanosis)

Organisms
of bacterial
vaginosis
ß Haemolytic
streptococcus
Cervical
lesions –
warts,
chancre,
herpes
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Genital
Growths

5
The Diagnosis of RTIs
Laboratory Diagnosis

The depth and
scale of
laboratory testing
can be adapted
for appropriate
use at different
levels of a health
care service

This is both the most accurate and, generally, the most costly
approach to diagnosis. The depth and scale of laboratory testing
can be adapted for appropriate use at different levels of a health
care service (see Table 3); but it is important to recognise that
even the most basic testing and diagnostic procedures (such as
Gram stain or wet mount) are contingent upon the availability
of trained personnel and ongoing adequate supplies of reagents
and/or infrastructure (such as a microscope, electricity supply, etc.).
What is an “ideal laboratory test”?
To judge whether a diagnostic test should be introduced at a particular
level of health care, the following criteria must be taken into account:
!
Sensitivity of the test (proportion of true positives identified)
!
Specificity of the test (proportion of true negatives identified)
!
Cost (to both the patient and the health system)
!
Feasibility (for both the laboratory and the health system. Includes
logistics, personnel, training, etc. requirements)
!
Acceptability of the test (a test which involves the use of hard-toobtain samples may be unacceptable to the affected individual)
!
Reliability (repeated tests on the same sample produce the same
result)
!
Availability (tests which are only available in specialised settings are
clearly not recommended for use throughout the health system)

Clinical Diagnosis
This relies on the individual health-care worker making a
diagnosis after clinical examination. Studies have shown that
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this form of diagnosis generally has a low sensitivity and
specificity when compared to ‘gold standard’ laboratory tests* .
The reasons for this are:
!

low specificity of clinical symptoms and signs

!

inaccurate interpretation of normal clinical features and
signs, especially in the female genital tract

!

occurrence of mixed infections.

Rapid Diagnostics
In order to increase the value of case management strategies,
rapid diagnostic testing for STIs has been suggested as one part
of the solution. These rapid tests are simple testing procedures
which are easy to use at all levels of the health care service and
provide a test result at the point- and time-of-care. Although
there are currently several test kits which are commercially
available, there is very little information on the efficacy of their
use in primary health care (PHC) settings, and little data on their
effectiveness (sensitivity, specificity, etc) and utility in “real
world” settings. Trials of these diagnostic kits are planned in the
near future.
The Role of the Laboratory
Table 3 gives examples of the laboratory tests which may be
carried out at different levels of the health system. It will be
seen that not every organism can be diagnosed even at basic
levels of health care, and some require full-scale laboratory
facilities for diagnosis (e.g the laboratory diagnosis of
Haemophilus ducreyi is probably only possible in fully equipped
settings). Programme managers should make decisions on
diagnostic capabilities depending on a number of factors
including: costs of diagnosis; cost of diagnosis per true case
identified (if such information is available); laboratory facilities
available; presence of trained staff; ability to maintain a regular
supply of necessary laboratory equipment and supplies. In many
*Gold standard laboratory tests provide the highest level of sensitivity and
specificity for the diagnosis of any named organism
15

Rapid tests are
simple testing
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are easy to use at
all levels of the
health care
service

Table 3
Recommended diagnostic tests by level of laboratory capability
Disease

Laboratory test

Neisseria
gonorrhoeae

Smear (Gram, methylene
blue, safranin)
Culture
ß-lactamase
Antimicrobial susceptibility
PCR
Chlamydia
Antigen detection
trachomatis
DFA
ELISA
DNA hybridisation
Culture
Serology
PCR
Syphilis
Darkfield microscopy
RPR
TPHA
FTA
IgM
Human
Cervical cytology
papilloma virus PCR
Genital herpes Antigen detection
Culture
Serology
PCR
Chancroid
Culture
Antimicrobial susceptibility
PCR
Donovanosis Smear (Leishman, Wright)
Histopathology
Trichomoniasis Wet mount microscopy
Culture
Candidiasis
Wet mount (cv.+10% KOH)
Culture
Bacterial
Wet mount, stained smear,
vaginosis
pH, KOH sniff test
+ Yes

(+) yes, if possible

Peripheral Laboratory level
Intermediate
+
+

Central/
STD centre
+

-

+
(+)
-

(+)
+
+
-

(+)
(+)
+
(+)
(+)
+
+
-

+
+
(+)
+
+
+
+
+
+
+
+
+
+

+

+

+

- No

Source: Gina Dallabetta, Marie Laga, and Peter Lamptey(eds.) 1986. Control of Sexually Transmitted Diseases:
A Handbook for the Design and Management of Programs. AIDSCAP/Family Health International, pp231.
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+
+
+

+
+
+
+
+
+
+
+
+
+
+
+

cases, one of the most pragmatic decisions to be made is the
‘cost’ of waiting for a laboratory result as against immediate
treatment of a symptomatic client (will s/he return for the
results; will further transmission occur whilst results are
awaited?).
One of the most important roles of the microbiology laboratory
in RTI/STI control programmes is as a facility for monitoring
and evaluating activities – e.g. monitoring patterns of antibiotic
susceptibility; and evaluating local case management strategies
against gold standard laboratory results.
Points for Programme Managers
RTIs can be diagnosed according to a number of criteria: laboratory
[aetiological diagnosis]; clinical; or syndromic. Choice of which criteria
to use depends predominantly on the resources available at different
levels of the health care system.
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6
Prevention and Care of RTIs
Prevention of RTIs encompasses various programmatic and
individual level perspectives depending on whether control is
aimed at the endogenous, sexually transmitted or iatrogenic
infections. These issues are addressed in more detail in
section 7. Nonetheless, for all types of infection, there are
several common interventions which can be highlighted:

6.1 Promoting Effective Health Care Seeking
Interventions to change health care seeking behaviour aim to
change the following outcomes:
One of the major
challenges in India i. time taken to seek care if symptomatic
ii. numbers seeking care from a trained health care provider
is to persuade
iii. numbers persuading partners to seek care.
symptomatic
people to seek
One of the major challenges in India is to persuade symptomatic
care from qualified people to seek care from qualified practitioners. Behavioural
practitioners
surveillance data from Tamil Nadu in the period 1996-2000
have shown a relatively consistent percentage of men who
report symptoms of urethritis in the past year, but while the
percent of symptomatic truckers who sought care from a
qualified allopathic doctor has increased, it has correspondingly
decreased among male factory workers and male students.
Indeed, less than one-sixth of all symptomatic students had
sought care from a qualified doctor. Such findings are
corroborated in the NACO estimate that between only 5 and
10% of people with STIs seek care in the public sector.
Points for Programme Managers
Timely health care seeking from trained providers is the key for ensuring
effective case management. Patterns of health seeking will change if
people can be assured of high quality and effective treatment
from providers.
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6.2 Case Management of Symptomatic Individuals
Traditionally, management of patients with RTIs/STIs has relied
upon the results of laboratory tests or has been based upon the
clinical judgment of the individual practitioner. As discussed
above, in many settings these approaches may not be optimal
and/or feasible. Recognising that in most resource poor settings
there are no widespread laboratory facilities and there are
relatively few trained STI/RTI specialists, the World Health
Organization (WHO) has developed a set of management
guidelines specifically for low-income, low-resource settings:
syndromic management algorithms. The National AIDS Control
Organization (NACO) has recommended syndromic
management for case management, especially at the primary
health care level.
WHO has
developed a set
The syndromic management approach relies on being able to
of management
identify and treat the clinical syndrome caused by an
guidelines
endogenous infection or STI. A syndrome is defined as the set
specifically for
of symptoms and/or signs that an individual suffers from and
presents with in health-care settings. Among the many values of low-income, lowresource settings
this approach is that it is relatively simple to use, and can be
incorporated into all levels of the health care system – even at
primary health care levels; and can be useful in both the public
and private sectors. The syndromic approach recognises that
there are several different organisms that can cause a particular
set of symptoms or signs and recommends treatment for the
most common group of aetiological agents which may be
present. These syndromes and their common aetiologies were
outlined in Box 2.
Studies have shown that the most common presenting symptom
in female patients – vaginal discharge – is relatively poorly dealt
with when using syndromic management. The lack of specificity
of this symptom, and the difficulty interpreting clinical signs
may mean that women are over-diagnosed and over-treated for
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STIs when they are in fact only suffering from endogenous
infections. Conversely, the asymptomatic carriage of Neisseria
gonorrhoeae and/or Chlamydia trachomatis can lead to a low
sensitivity of the recommended algorithm, resulting in infected
women not being treated.
An additional problem is that the ability of health workers to
adhere to the recommended clinical algorithms has been shown
to be poor, especially in the case of vaginal discharge.
However, trained and experienced clinicians have been shown
to achieve a higher sensitivity for detecting cervical infections
during clinical diagnosis, than other health workers. This carries
clear implications for resource management and personnel
placement in health-care programmes.
The ability of health
workers to adhere
to the recommended
clinical algorithms
has been shown to
be poor, especially
in the case of
vaginal discharge

Behavioural risk assessment has been introduced to try and
distinguish between those women with an STI as a cause of
their symptoms, and those suffering from an endogenous
infection. Evaluations of behavioural risk assessment have been
carried out in several settings in sub-Saharan Africa, and
elsewhere in the world, and have shown that the introduction of
this step into the syndromic algorithm increases its specificity
and positive predictive value, but sensitivity may remain a
problem. Similarly, other researchers have found that performing
internal gynaecological examinations can improve the
performance of adapted algorithms.
Other evaluations of syndromic algorithms have shown that
they can work well in the case of clients with genital ulcers and
for symptomatic men with urethral discharge, and possibly for
men with dysuria (pain passing urine) as their main symptom. It
should be noted, however, that most evaluations have been
undertaken in areas with a reasonably moderate to high
prevalence of STIs.
A final note of caution: treatment for many of the organisms
mentioned in Box 2 (aetiologies of common syndromes) is
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unlikely to be available at all levels of the health care system.
For example, treatment of genital warts (either with drugs or, for
example, cautery) is unlikely to be feasible in primary health
care settings.
Points for Programme Managers
Global reviews of syndromic management have found that this
approach works well for symptomatic men and for men and women
with genital ulcers. For women with vaginal discharge, however, the
algorithms must be adapted to the local epidemiology and aetiology,
when this is known.
A study carried out in New Delhi among over 300 symptomatic women
seeking care in a NGO reproductive health clinic reported a reasonably
high STI prevalence: 22% of women had an STI (chlamydia,
trichomonas or syphilis; none with gonorrhoea) diagnosed by the
laboratory, including 12% with Chlamydia trachomatis. Syndromic flow
charts performed well for the management of vaginal infections, but
the STIs were poorly managed with only 5% of women infected with
chlamydia receiving appropriate treatment.

6.3 Partner Management
Partner management is seen as a cornerstone of effective STI
management. It is premised upon the fact that if only the “index
patient” (that is, the client presenting for care) is treated, then s/
he is likely to be re-infected if her/his sexual partners are not
simultaneously treated. By treating sexual partners of patients,
whether symptomatic or not, re-infection can be halted and
ongoing transmission curtailed. There are number of possible
strategies for partner management:
!

!

The patient contacts partners his/her self, and advises them
to seek care;
Provider management where providers obtain information
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Gram smear showing Gram negative
intracellular diplococci

Treponema pallidum - causative
organism of syphilis

- suggestive of gonorrhoea

KOH wet mount with budding yeast
cells-Candida specis

Saline wet mount with organisms of
Trichomonas vaginalis

Epithelial cells covered with small
bacteria - seen in bacterial vaginosis
Source: JHPIEGO
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Lesion of primary syphilis

Lesions of genital herpes

Genital warts

Clinical picture of candidiasis

Discharge associated with
Trichomonas vaginalis infection
Source: JHPIEGO

23

from patients and contact the partners themselves (this is
the most costly approach);
!

In STD clinics in
India, counselling
for prevention is
inadequate and
poor

Combination referral where a mixture of the above two
methods is employed.

Partner management can be integrated into all settings where
STI care is provided but studies in India have shown that this
procedure is rarely discussed or initiated by health care
providers. A clinic based study in Chennai, observed that advice
on partner management was given during only 27% of the
consultations. Likewise, a study in Delhi reported that none of
the 100 male and female STD patients were advised about
partner management. In a community-based study in rural Tamil
Nadu, none of the symptomatic women and only 5.7% of the
symptomatic men were advised to have their spouses examined
for a possible infection.
Points for Programme Managers
Partner management (PM) is an essential component of STI control.
The most acceptable and effective methods of PM should be evaluated
for local population settings. Options include provider-led referral,
client-led referral and combinations of the two.

6.4 Counselling for Prevention
The few studies on this issue in India have found that in STD
clinics, counselling for prevention is inadequate and poor.
Observations of STD consultations in Chennai revealed that
advice of condom use for prevention of STDs was given during
only 30% of the consultations. Instructions on how to use
condoms were imparted to 6% of the clients and condoms were
provided to 1%. Similarly, in a study conducted in Tamil Nadu,
only 15% and 28% of the symptomatic women and men
respectively that had sought treatment from a health care facility
were informed by the providers about the cause of their
symptoms or the precautions to be taken to avoid the illness.
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Points for Programme Managers
STI counselling, including condom promotion, is an essential part of
prevention and care activities for STI patients. Instructions on the correct
use of condoms should be given, and condoms should be either
distributed or sold, or advice given on where to obtain high quality,
low cost condoms.

6.5 Improving Treatment Adherence
Not complying correctly with recommended and standard
treatment guidelines for therapeutic regimens can be due to a
number of factors, all of which can result in sub-optimal doses
of the recommended regimens:
!

Being given erroneous treatment advice by the health care
worker

!

Not understanding the treatment recommendations

!

Not finishing the recommended drug course

This latter point often arises when people are prescribed long
courses of antibiotics and only take part of the course because
their symptoms regress after a few doses. Such is the path
towards antimicrobial resistance. In order to reduce the
likelihood of this outcome, there are a number of programme
interventions which can be undertaken.
Points for Programme Managers
Failure to complete a course of treatment can lead to chronic infections
as well as increasing the likelihood of antimicrobial resistance. This can
be minimised by:
!

Training all health workers to advise people to finish their
recommended drug courses

!

Simplifying drug courses, for example through the use of single
dose regimens
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7
Public Health Approaches to RTI/STI Control
As we have seen, there are three categories of RTI: endogenous
infections; sexually transmitted; and iatrogenic. Programme
interventions to address these three categories of infection are
interlinked and often implemented by the same staff.

7.1 Control of the Endogenous Infections

There are a wide
variety of factors
which put women
at risk of
endogenous
infections

There are a wide variety of factors which put women at risk of
endogenous infections (mainly bacterial vaginosis and
candidiasis) including, but not limited to:
! Certain types of contraceptive use (including higher dose
oral contraceptives)
! Vaginal douching
! Pregnancy
! Use of antibiotics
Control strategies for these infections would include promoting
the rational use of antibiotics and use of lower dose oral
contraceptives. Other risk factors need to be assessed for the
individual woman.

7.2 Control of Iatrogenic Infections
Non-sterile procedures across the cervix can result in the
upwards transmission of organisms from the lower reproductive
tract into the upper tract. In order to prevent this, the following
steps should be promoted:
! Care seeking from skilled and qualified health workers
! Screening for infections before undertaking a transcervical
instrumentation
! Advising the client to return immediately if there are any
abnormal symptoms following such a procedure
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7.3 Control of the Sexually Transmitted Infections
The principle steps in achieving STI prevention and care are
illustrated in the ‘inverse pyramid’ model of Piot and Fransen.
This has been adapted for Figure 1. This model highlights the
areas where STI prevention and care programmes should target
efforts to reach greater numbers of infected men and women.
Some of the issues and areas addressed in the following sections
apply to other RTIs as well as the STIs
Figure 1
Suggested programme level interventions for STI control
Whole community

Primary prevention
Mass treatment options
Vaccination programmes
Prophylaxis against infection
Number of people infected in community
Raise awareness of asymptomatic infections
Screening programmes
Number aware of infection
Improve health care seeking procedures
Number seeking health care
Improve case management procedures
Number correctly dignosed
Improve partner management
Improve patient adherence
Number correctly managed
Appropriate drug regimens used
Antimicrobial resistance patterns known
Number cured
SHOULD INCREASE
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In the following sections, we will concentrate on the first two
steps outlined in Figure 1 i.e. public health interventions. The
remaining steps have been explored in detail in Section 6.

7.4 Behaviour Change Communications for RTIs/STIs
It has been well substantiated by behavioural scientists that real,
long-lasting behaviour change is not the result of simply telling
people what to do. Programmes - that tell people ‘AIDS Kills;
Use a Condom’, or ‘A Small Family is a Happy Family’ will only
Box 3
Behaviour Change
It has been well
substantiated by
behavioural
scientists that real,
long-lasting
behaviour change
is not the result of
simply telling
people what to do

Sustained behaviour change occurs after an individual has moved
through various stages described below:
Stages of behaviour change
An individual…..
is unaware of problem
becomes aware of problem
is concerned that behaviour places him or her at risk.
acquires knowledge about the problem
is motivated to act through perceived risks and benefits.
is ready for action through skills acquired to enact change
tries new behaviour
assesses the efficacy of changing behaviour and, if successful
sustains behaviour change.
To summarise, in order for their behaviour to change, individuals
must perceive the following:
! They are at personal risk
! Changing their behaviour will result in benefits that are relevant
to them
! Social norms will support their actions at each stage of
behavioural change
! They have the skills and resources needed to make the
changes.
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be effective if the message is understood by the clients, seen as
beneficial, and in accordance with their needs and values.
Communications that do not follow this basic premise are rarely,
if ever, effective in achieving behaviour change objective.
To be successful and effective, communication programmes
must be based on behaviour change theory, sound public health
practice, and well-designed audience assessment combined with
innovative communication strategies. Above all, the complex
tasks of addressing an issue as sensitive as RTIs/STIs and
promoting changes in behaviour that are often deeply ingrained
and personal must be approached with a comprehensive,
systematic plan that maximises impact.
Behaviour change communications involve understanding the
individual’s needs, concerns, and perceptions and therefore
successful communications programmes must pay attention to:

!

Behaviour change
communications
involve
Behavioural objectives
understanding the
individual’s needs,
Identifying the audience
concerns, and
Message development and appropriateness for each audience
perceptions
Channels of communication/sources

!

Evaluation and feedback

!
!
!

Behavioural Objectives
These include:
!

A change in knowledge, behaviour or attitude

!

A change in knowledge about STI/RTI, causation,
transmission, prevention or treatment

!

Increase in the number of trained counsellors or workers
skilled in communication

!

Increased condom use or access
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!

Abstinence or condom use during the treatment duration

!

Fewer repeat STI cases

!

Improved STI/RTI referrals or partner notification and/or
management

!

Reduced incidence of unsafe deliveries, abortions or other
trans- cervical procedures

Identifying the Target Audience

Target audiences
are groups of
people who have
common
characteristics
related to disease
prevention and
control

Target audiences are groups of people who have common
characteristics related to disease prevention and control. These
could be primary or intermediary audiences. Targeted primary
audiences may include groups such as adolescents, high risk
groups, drug users etc. Other groups that could be targeted for
STI/HIV/AIDS prevention and control programmes are health
workers and teachers who could be the intermediaries to the
primary audiences. Segmenting the audiences is useful as
messages developed are then relevant to the needs of a
particular group.
Group characteristics can be identified on the basis of high-risk
behaviour; demographic factors; psycho-graphics; ethnicity,
language and sexual orientation; organisational or institutional
structures.
Given below are examples of questions that programme
planners can ask in order to learn more about the members of a
particular target audience:
!

What do members of this target audience know about RTIs/
STIs?

!

What are their concerns about RTIs/STIs?

!

What behaviours put them at risk for RTIs/STIs?

!

What do they do to avoid RTIs/STIs?
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!

What are the language, literacy and/or cultural barriers?

!

What are some of their perceptions about how RTIs/STIs
are acquired?

!

What are the special needs of this group?

!

Who are the leaders or who has influence over this group?

Quantitative research (surveys) and qualitative research (focus
group discussions and interviews) can help answer key questions
about a target audience. Findings from secondary data sources
can also help in arriving at answers to questions posed above.
Developing Key Messages
Careful attention needs to be paid to message development to
ensure that the messages are not misinterpreted or lead to
unintended results. The messages chosen should enable the
target audience understand the specific benefits of following the
health recommendations and changing behaviour.
It is also important to give members of the target audience an
opportunity to respond to message concepts, materials and
delivery formats before they are finalised.
Focus groups and interviews are effective methods for
developing messages and for pre-testing developed
communications products and materials.
Some examples of pre-test questions are:
!

What is this message telling you?

!

Is this important to you? Why or why not?

!

Who do you think should hear these messages?

!

Which is an appropriate place to display the messages?

!

What do you like/dislike about the messages/materials?
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target audience

Selecting Channels of Communication
The choice of communication channels will depend on many
factors, including the programme objectives and the target
audience’s access to and preference for a particular channel. For
example, the mass media are very effective in promoting a
general understanding of a problem or issue, whereas
interpersonal channels are effective in changing specific and
individual attitudes and behaviour. The following information
channels are suitable for delivering RTI/STI messages:
The mass media
are very effective
in promoting a
general
understanding of a
problem or issue,
whereas
interpersonal
channels are
effective in
changing specific
and individual
attitudes and
behaviour

!

Mass media including televisions, radio, audio-visuals,
newspapers and magazines. Within these formats, messages
can be embedded in the story lines of radio, audio-visuals,
television, and folk dramas; or RTI/STI awareness can be
raised through news story or through clinic advertisements
in local magazines/newspaper. For example, an urban-based
NGO used a widely-circulated magazine to place
advertorials on RTIs.

!

Published media including pamphlets, posters, flip charts,
displays, models, booklets and audio and video cassettes.
Some of these channels are used to provide information
(e.g., pamphlets, flip charts), and others are used to remind
people of earlier learning and previous decisions (e.g.,
posters).

!

Institutional and interpersonal networks including centres for
formal and non-formal education, factories, women’s
groups, unions, professional associations, social groups,
families, etc. Information disseminated through these
groups by peer educators or by visiting “health workers” can
be very influential in supporting individuals to understand
their symptoms and make the necessary behaviour changes.

!

Health service delivery systems including counselling and client
education (see Box 3) programmes in clinics; HIV
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counselling and testing centres, community based
distribution networks can be effective channels through
which to deliver RTI/STI information and prevention
messages.
!

Training programmes for health workers/providers that
include IEC material on local terminology; safe delivery
guidelines; clean abortion procedures, etc.

!

Peer education is an approach that can be considered a
channel or an intervention. Information disseminated
through peers often has more credibility, immediacy, and
impact than through more formal and distant channels. Peer
educators have worked successfully among high risk groups
such as truck drivers, adolescents, CSWs, men who have sex
with men, and among out of school youth, university
students, health workers, and teachers.

A programme manager can use several channels to reinforce
RTI/STI information and prevention messages. For example, an
audio-visual dealing with personal hygiene could be viewed by a
group of young women. Following that a group discussion (or
role-playing exercise) that provides key information as well as
elicits key concerns could be organised.
Evaluating the Programme
Evaluation is frequently cited at the end of the communication
process, but it should be built into the communication
programme as it is being designed. Based on key questions,
evaluation helps determine whether and how well the project is
achieving its goals and objectives. Process evaluation examines
the steps involved in implementing the programme. Outcomes
describe the immediate effects of the programme such as the
knowledge gained and attitudes changed; the short-term
behaviour shifts; any policy or other institutional changes.
Impact, the most comprehensive evaluation, focuses on the
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STI information
and prevention
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long-range effects of the programme (e.g. whether RTI/STI
incidence was reduced as a result of the programme).
Some of the following questions can provide important
feedback on the programme:

Mid-course
corrections can
then be made to
improve the
activities and
increase the
likelihood of their
success

!

If individuals are not taking the educational materials
provided, the distribution methods should be assessed. Are
they left in conspicuous places? Are they available where
the key audiences congregate? Should they be distributed
personally by the health care providers or by peers? Are
people too embarrassed to be seen with them? Would a new
design be more appealing or attractive?

!

If clients are not coming back for follow-up visits, do the
health care providers need more training in counselling,
patient education or interpersonal skills?

Answering these questions will give feedback and help identify
the project’s strengths and weaknesses. Mid-course corrections
can then be made to improve the activities and increase the
likelihood of their success. Answering such questions early in
the project will lead to refinement of the communication
strategies and increase the effectiveness of the overall programme.
Points for Programme Managers
Communication programmes for RTI/STI control and prevention
need not rely on expensive materials or the latest in technological
innovations to be successful. If properly planned and implemented,
communication activities both within and outside the treatment settings
can make an important contribution to RTI/STI prevention and control
programmes. The programme manager is encouraged to identify and
contact local resources. These include advertising or public relations
agencies, professional writers and editors, and other communication
experts in health departments or non-governmental organizations (NGOs).
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Box 4
Client Education
Client education centres on behaviour change advising in a clinic setting as a viable approach to
encourage a behavioural risk-reduction. Since it is generally accepted that education as informationgiving alone is not a sufficient prevention strategy, education in this context includes motivational
messages and approaches to changing behaviour as well as providing factual information.
Telling a client how RTIs/STIs are transmitted and how they can be treated may be informational.
In client education the session might include an advisory component, such as ‘take your pills in
the morning; do not take them on an empty stomach; or it is important to discuss symptoms
with your partner’. It is different from counselling in that “counselling” is generally accepted by
mental health professionals to mean in-depth, long-term and repeated interactions between a
trained counselling professional and a client covering topics that can be very broad in scope and
emotional in nature. For this reason, the phrase “behaviour change advising” is preferred. This
conveys the idea that in a clinic setting, there are usually limited human resources available and
the interaction between client and health care worker may be brief as well as restricted to only
one encounter.
There are many reasons supporting the use of a clinic visit as an opportunity for client education:
It is efficient because it reaches the patient where the patient is
! If you can prevent RTIs/STIs, you can prevent associated sequelae
! The time is right. Clients are likely to be motivated to find out how to avoid the same
discomfort in the future
! Preventing future visits contributes to the community’s overall productivity
! Treatment is more likely to be effective if a client understands the regimen
! Effective client education is part of delivering quality reproductive health care
!

One aspect of client education that is sufficiently recognised is the potential for a multiplying
effect when clients take home information and materials and discuss what they have learned
with family members and friends. If the community has an active outreach education
program, this clinic-based education can reinforce those efforts.

What the client needs to know
Recognition and Prevention Measures
!
!

Physical symptoms (what to look for and what it means)
Personal hygiene procedures
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!
!
!

Condom use
Partner communication
Alternatives to penetrative sex

RTIs
!
!
!
!

Factors causing RTIs
How RTIs/STIs are passed between people
Consequences of RTIs
Relationship of RTIs/STIs and HIV/AIDS

Treatment
!

!

How to take medicine (with what other substance and for how
long)
Signs that call for a return to the clinic
Importance of partner referral and treatment
Abstinence or condom use during the treatment

Mass treatment is
!
an alternative and
!
more radical
approach to
7.5 Mass Treatment
reducing the high
numbers of people Mass treatment is an alternative and more radical approach to
infected with STIs reducing the high numbers of people infected with STIs. Whole
communities, or selected populations within communities, are
given regular repeated doses of drugs against bacterial
infections. Its main advantage is that of addressing infection in
asymptomatic individuals. Other benefits include no diagnostic
tests needed, a modest training for health workers, and
participants can be treated at home. However, mass treatment
can be an expensive strategy and repetition of repeated drug
doses carries a potential danger of antibiotic resistance both
among RTI/STI pathogens. Some experts have also voiced
serious doubts about sustainability and long term effectiveness
of mass treatment for STIs.
Examples of mass treatment include those conducted in the
Rakai District, Uganda, which assessed whether this
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intervention resulted in reduced HIV incidence. Mass treatment
was offered to all subjects in the intervention arm, whether
symptomatic or not, and independent of laboratory testing
(except for syphilis). HIV incidence was equivalent in both
arms of the study – indicating that this approach did not work
in this community. Other mass campaigns in pursuit of the
eradication of syphilis in Bosnia-Herzegovina (1948-1955), in
Indonesia (1958-1982) and in China (in the 1960s) were more
successful. More recent examples of mass treatment being used
with success are found in programmes which have undertaken
‘targeted mass treatment’. For example, in the mining towns of
South Africa, interventions giving mass treatment to sex
workers resulted in a concomitant fall in the number of new
infections in the miners, their main client group.

7.6 Vaccination Programmes
There are no vaccinations currently available against sexually
transmitted infections or the endogenous infections. However,
there is an effective vaccine against hepatitis B – a virus which
can be sexually transmitted, but which is most often acquired
through materno-fetal infection or childhood transmission in
endemic countries. The recommended schedule for control of
hepatitis B is to add the vaccine into the routine childhood
vaccination programme - this approach has been recommended
for India.

7.7 Prophylaxis Against Infection
Prophylaxis is only recommended for one preventable
condition: ophthalmia neonatorum (ON). This is a potentially
sight-threatening eye infection in infants, due to Neisseria
gonorrhoeae or Chlamydia trachomatis transmitted from the mother
at the time of delivery.
Strategies for the control of ON include:
(a) preventing infection in the mother,
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(b) treating infected pregnant women before they give birth;
(c) managing individual cases of infection in neonates; and
(d) prophylaxis in all neonates at birth.
Whilst the first of these four options remains the ultimate goal
of most STI control programmes, programme managers are
currently faced with the question of how to manage or prevent
infection in infants. This situation arises in part because the
possibility of screening all pregnant women before birth and
finding all those who are infected remains low.

ON prophylaxis is
both cheap and
simple to
administer

Thus, the choice for most programmes will be between case
management of infected infants, or ocular prophylaxis of all
infants. Active case management of a child with gonococcal or
chlamydial ophthalmic infection generally presents a much larger
challenge to the health-care system. Correct management of the
neonate ultimately relies on the parents/carers seeking
treatment from a trained provider who can correctly diagnose
and manage ON. It is felt that this assumption is too great a risk
to take when the possibility of preventing infection in the first
place is both simple and inexpensive.
ON prophylaxis is both cheap and simple to administer. The
choice of regimen will depend on the local cost of the drugs,
the incidence of ON (both commonly used drugs have some
degree of failure – higher for silver nitrate than for tetracycline),
and the ability of health care personnel to correctly manage the
storage and handling of the drugs (especially silver nitrate) in
order to minimise the likelihood of chemical conjunctivitis.
Given that ON prophylaxis should be administered within the
first few hours after birth, it is clear that any programme to
prevent ON through the use of topical prophylaxis will be
dependent upon adequate training of those most likely to be
involved in the delivery of infants.
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7.8 Raise Awareness of Asymptomatic Infections
Whilst there are many published studies on the prevalence of
asymptomatic infections in communities, there are unfortunately
few working programmes addressing this issue. The sexually
transmitted infections, chlamydia and gonorrhoea, have been
found to be carried asymptomatically in a majority (over 50%)
of infected men and women. Syphilis only causes symptoms for
a short period of time and then enters a latent phase when it can
only be detected through blood testing although it is still
potentially harmful to the infected individual and her unborn
child. This clearly creates a problem in designing appropriate
programme responses. In the absence of widespread screening
facilities, individuals who are infected but asymptomatic must
be reached through a variety of other strategies. These might
include:
!

Partner management

!

IEC campaigns persuading people who believe themselves
to be at risk of infection to attend for a genital health
check-up

!

Training health workers to consider the possibility of
asymptomatic infection in people seeking care for other
services – i.e. case finding. This approach relies upon having
screening facilities available in the health services.
Prophylactic use of antibiotics in people thought to be ‘at
risk’ but not the partners of known-to-be-infected persons,
is not recommended.

7.9 Screening Programmes
Case finding is a process of opportunistic screening for an
infection at a time that an individual presents to a health facility
regardless of the presence of symptoms. Case finding among
family planning clients is an important opportunity to detect and
counsel about these infections when women and men present
for contraceptive services.
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Screening usually implies wider coverage and attempts to
identify an infection in a (whole) population which does not
usually access services. Widespread screening strategies for the
common STIs (chlamydia and gonorrhoea) are unlikely to be
feasible in resource poor settings. However, there are situations
when screening should be considered - for example among
antenatal clinic attendees, when the benefits of screening are
clear.
The most common screening programmes worldwide are those
for detecting syphilis in pregnant women. Untreated syphilis in
pregnancy is associated with a number of adverse outcomes:
pregnancy loss; stillbirth; congenital syphilis. It is estimated that
only one third of pregnancies in mothers with untreated syphilis
will result in a normal healthy baby. A further third will end in
The cost of syphilis
spontaneous abortion or neonatal death, and the remaining third
screening is low
will produce children with congenital syphilis. Such a high rate
and the diagnostic
of materno-fetal transmission, the severe physical, mental and
technology is
emotional consequences of congenital syphilis, combined with
simple to use
the relative ease, high sensitivity and specificity, and low cost of
both screening and treatment, have established screening
programmes as a cornerstone of syphilis control.
The cost of syphilis screening is low and the diagnostic
technology is simple to use. Similarly, the cost of treatment for
each serologically reactive woman is also low. It has been shown
that even when the prevalence of syphilis is as low as 1 in 1000,
screening pregnant women is still a cost-effective intervention
compared with not screening and treating women at all.
Screening programmes for syphilis rely upon the use of simple,
inexpensive tests (most usually rapid plasma reagin, RPR, or
Venereal Disease Research Laboratory, VDRL) which can be
undertaken at the PHC level. Treatment is then administered to
any woman with reactive serology and she is encouraged to
bring her partner in for treatment. Whilst there is a possibility of
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a low level of overtreatment if only screening test results are
used, (due to the lower specificity of RPR or VDRL compared
to the confirmatory test) this is usually outweighed by the
benefit of treating a woman immediately instead of asking her
to return, collect results and then undergo treatment.

7.10 Which Interventions Should Programme Managers
Use?
As we have seen above, there are a number of effective
interventions which can be incorporated into RTI/STI control
programmes. It is important to remember that priorities for
programme interventions are often set according to economic
priorities – usually because these are among the easiest variables
to measure, and because programmes have to be financially
accountable. In the case of RTIs, this often leads to a focus on
the control of the sexually transmitted infections because they
are more likely to have serious outcomes and sequelae.
Nonetheless, the endogenous infections are often more
common, especially in women, and effective management of
these infections should not be overlooked.
For programmes to be appropriate and effective, it is important
to consider other factors in addition to the economic ones. The
exact mix of interventions chosen should depend upon the
prevailing social, cultural, political, economic and logistical
factors prevalent locally and should be targeted to the local
epidemiology and aetiology of common RTIs/STIs. In other
words, in order to design appropriate and effective programmes
it is important to have some knowledge of the infections which
are being targeted, and the groups most at risk for each type of
infection. Programme managers can then decide which of the
known-to-be-effective interventions are most appropriate for
their particular setting. In making these choices, Table 4 aims to
guide programme managers in looking at the range of possible
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interventions which may be appropriate in their particular
setting. There may be some interventions which are critical and
should be implemented immediately, whilst others may need
more information, assessment and planning. Examples of the
former may include screening pregnant women for syphilis,
whilst the latter might include programmes to change health

Table 4
Prioritising programme interventions
a) Symptomatic Individuals
Intervention

Sexually Sexually Pregnant Family
Infants Groups
‘Vulnerable
Active Active Women Planning
Requiring Groups’
Men
Women
Clients
Targeted
Interventions

1. Encourage
appropriate and
prompt care
seeking behaviour
2. Standardise case
management
3. Improve treatment
adherence and
abstinence during
treatment
4. Clinic-based
counselling for
prevention
(including condom
promotion and
voluntary
counselling and
testing)

42

seeking behaviour. Table 4 can be used to plan interventions
which might be appropriate in the short, medium and longer terms.
The table is not a blueprint for programme design, it merely
serves to emphasise that there are a number of ‘target’
audiences to be considered, and a wide variety of interventions
that may be appropriate and effective in addressing the
management of established RTIs among these infected women
and men.

b) Asymptomatic Individuals
Intervention

Sexually Sexually Pregnant Family
Infants Groups
‘Vulnerable
Active
Active
Women
Planning
Requiring Groups’
Men
Women
Clients
Targeted
Interventions

1. Mass
screening
2. Selective
screening
3. Partner
referral
and
treatment
4. Presumptive
treatment
Notes on Table: Each box requires a programmatic decision concerning the appropriate action to
pursue. Many of the boxes will not require any decisions to be made. For example, the appropriate programme response for infants will usually be Presumptive Treatment (ON prophylaxis) and
all other boxes will remain blank. Similarly, pregnant women should be offered mass screening for
syphilis. Other interventions will depend upon the particular local context, taking into account
the range of contributing factors as discussed.
Groups which may require targeted interventions include those known or perceived to be at
higher risk of infection. Examples may include commercial sex workers and their clients. Vulnerable groups may not necessarily have higher rates of infection, but may be potentially exposed
to risk. Examples might include adolescents and migrant workers.
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Points for Programme Managers

The endogenous
and iatrogenic
infections are
found
predominantly
among women

The highest public health priority is for primary prevention of
infection. Primary prevention efforts are not 100% successful,
however, resulting in a need for additional interventions to
address the problem of established infections of the
reproductive tract. A comprehensive mix of interventions
should focus on: enhanced symptom recognition and
appropriate health care seeking behaviour; screening (e.g. for
cervical cancer, or among pregnant women for syphilis);
prophylaxis (e.g. against ophthalmia neonatorum); vaccination
(e.g. against hepatitis B); effective outreach programmes to
identify symptomatic men and their sexual partners; and
improved quality of clinical services for women and men. The
appropriate mix of interventions for each local and/or national
programme is determined by a number of inter-related factors:
!
!
!

!

!

Prevalence and incidence of RTIs
Cultural and social norms of sexual and health behaviours
Patterns of health care seeking behaviour including use of
public and private health services
Resources available at country level including structure of
public health programmes
Patterns of antimicrobial use and resistance

7.11 A Gender-based Perspective on RTI Programmes
The endogenous and iatrogenic infections are found
predominantly among women, and women are the usual focus
of public health programmes for the control of these infections.
In the case of the STIs, programmatic focus must include
comprehensive interventions for both men and women.
Sexually transmitted infections, including HIV, are more easily
transmitted from men to women than women to men. Studies
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have shown that women are twice as likely to become infected
by a variety of sexually transmitted pathogens (this may be
higher in the case of HIV). In addition, in societies where gender
inequities are strong (such as some parts of India) women may
be at greater risk of acquiring sexually transmitted infections
from men owing to social or cultural norms of behaviour which
preclude women the ability to refuse sexual intercourse with
their partners or to insist upon the use of barrier methods of
protection. Once a woman is infected with an STI, treatment
options available to her can be limited by a number of factors:
!

Her ability to seek care from trained and qualified providers
(Can she leave home without permission? Can she afford
effective treatment? etc.)

In societies where
gender inequities
are strong (such
as some parts of
! The high rate of asymptomatic carriage of the infecting
India) women may
organisms
be at greater risk
! The relatively poor performance of the syndromic diagnostic of acquiring
and treatment interventions recommended for women with
sexually
complaints of vaginal discharge
transmitted
infections from
! The power imbalances in many heterosexual relationships
men owing to
which reduce the ability of women to inform their partners
social or cultural
if they have an STI, and to protect themselves from
norms of
reinfection.
behaviour
Moreover, once a woman is infected with a sexually transmitted
infection, she has a higher chance that infection will result in an
acute or chronic complication (such as pelvic inflammatory
disease, chronic pain, infertility, cervical cancer or transmission
to an unborn child) than the equivalent infections in men.
To address these issues, programmes should be aware of and
respond to the biological, economic and social vulnerabilities to
RTI/STI transmission which are predominantly found in women.
This does not, however, mean that programmes should be
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focussed only on women. Indeed, given the fact that men are
usually more at risk of contracting STIs outside the home, and
that they are also more likely to have specific symptoms and
possibly to seek care, there is a strong argument for ensuring
that STI services for men are also strengthened in the hope that
they will be both management and prevention services.
Points for Programme Managers
Women are more at risk of all types of RTIs. In addition, social and
cultural factors often inhibit women’s ability to protect themselves from
infection, or even to seek care once infected. Nonetheless, in order to
be effective, STI control programmes must address the needs of both
men and women.

There is a strong
argument for
ensuring that STI
services for men
are also
strengthened

7.12 Sources of Data for Programme Managers
Typically, programme managers have imperfect data on many or
all of the factors mentioned in section 7.7. Under these
circumstances, the ability to make decisions on what constitute
effective interventions that should be included in a
comprehensive public health programme is often severely
hampered. Nonetheless, there are basic principles guiding
programme design, and these can be followed for RTI/STI
programmes. These principles include:
!

Knowledge of burden of disease

!

The effectiveness of ‘technical’ solutions

!

The cost-effectiveness of these solutions

In this document we have explored the first two principles in
relation to India – knowledge of the burden of disease in
different populations has been outlined (sections 2.2 & 2.3), and
the effectiveness of different ‘technical solutions’ was explored
in section 6.2. Evidence on the cost-effectiveness of different
interventions is mainly undocumented in the Indian context,
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leaving programme managers to make decisions predominantly
on the basis of burden of disease and available interventions.
Throughout this document we have stressed the importance of
knowing the local epidemiology and aetiology of the infections
to be targeted. It is clear, however, that in many instances this
information will not be available at a local level. In such cases,
there are several alternative options for determining local
epidemiology:
!

Rapid situational assessments with primary and secondary
stakeholders

!

Secondary data sources (such as records on admissions for
PID)

!

Cross-sectional surveys conducted by local researchers/
NGOs etc

!

Knowledge of the existence and size of groups at higher
risk of STIs in the target community

!

Data from local sentinel surveillance for HIV/AIDS

!

Medical college data on RTI/STI patients

These sources of information can be used to provide a
‘guesstimate’ of the prevalence of STIs/RTIs when active or
passive surveillance is not available to inform programme
design.
Points for Programme Managers
For programmes to be effective, they must be tailored to the local
epidemiology and aetiology of the infections they are aiming to control.
Surveillance systems provide the ‘gold standard’ of evidence as they
allow programme managers to monitor trends with time. In the absence
of surveillance systems, programme managers should look for
alternative sources of data to inform their decision-making.
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For programmes
to be effective,
they must be
tailored to the local
epidemiology and
aetiology of the
infections they are
aiming to control

8
Programme Monitoring
Basic principles of programme monitoring are included below,
but further details can be found in some of the references
mentioned in the bibliography.

Setting objectives
allows programme
managers to
determine what
types of
information they
will need to collect
as the programme
proceeds

Once programme managers have decided upon the most
appropriate mix of interventions for their own epidemiological
and aetiological situation, how can they monitor the programme
with regards to effectiveness and impact? The first step must be
to decide upon the aims and objectives of the programme itself.
Setting objectives allows programme managers to determine
what types of information they will need to collect as the
programme proceeds. The key to data collection activities is to
ensure that data are both useful and utilised. In addition,
feedback of results helps staff to see the purpose of data
collection and may increase their willingness to collect
meaningful and high quality data.
Monitoring activities should concentrate at least on the
following parameters:
!

Operational aspects of service delivery (e.g. client numbers;
diagnoses made; drugs distributed; condoms provided)

!

Staff and personal issues (e.g. proportion of staff who have
been adequately trained; supervision of staff)

!

Client satisfaction (e.g. how many visits are repeat or follow-up?)

!

Costs

!

Issues of quality of care – including partner management,
reinfection rates, referral rates, and management of side-effects.
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In addition to these activities, WHO has developed a series of
Programme Indicators that can be used for periodic monitoring
of programmes. Further information can be found in the
bibliography section.
Points for Programme Managers
Data collection activities are integral to ensuring the efficient and effective
running of services. Programme monitoring should be based upon
agreed objectives, and the flow of useful data should be bi-directional.
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Annex
Estimated No. of RTI Cases and Per Episode Cost for Drug Therapy
An Estimate for India:
1. Estimated number of eligible couples (15-45 years) per 1,00,000 population

17,000

2. Estimated number of women reporting RTIs symptomatics only
(30 per cent)

5,100

3. Estimated number of women who will be seeking treatment from
government health facility in the absence of intensive IEC efforts (25 per
cent of 2 above)

1,275

4. Considering 65* per cent RTIs to be associated with sexual mode of
transmission, partners to be covered for treatment

828

S. No.

Distribution Proportion Est. no. of
Unit Cost
Total
of morbidity
episodes per episode in Rs. cost in Rs.

Drug
regimen

1

Syphilis

7%

176

21.00

2,646

Benzathin
Penicilline,
Long Actg 24

2

Gonorrhoea

3%

76

9.00

450

3

Trichomoniasis

20%

510

4.00

2,040

Metronidazole
400mg 5 tabs

4

Candidiasis

25%

318 (women)
159 (men),
assuming 50%
sexual
transmission

7.00
30.00

2,226
4,770

Clotrimazole
500 mg Intra
vaginal tab
Fluconazole
150mg 1 tab stat

5

Bacterial
Vaginoisis

35%

450

4.00

1,800

Metronidazole
400mg 5 tabs

6

Chlamydia

10%

254

42.00

10,668

Norfloxacin
800mg single dose

Cap. Doxicyclline
100mg 1 BD for
7 days

* In high prevalence settings. These estimates will vary considerably depending on patterns of etilogical diagnosis for
RTIs in the area
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Foreword
Reproductive tract infections including sexually transmitted infections represent a
silent worldwide pandemic, which adversely impacts reproductive health of women
and men. Various community and hospital based studies in India have provided
insights into the magnitude of the problem.
The International Conference on Population and Development (1994), emphasised
integration of reproductive health services to meet the needs of men and women
especially with reference to prevention and management of RTIs/STIs. The
emergence of HIV and the identification of STIs as a risk factor for the spread of
HIV have further lent a sense of urgency for a programmatic response to address
this important public health problem.
Programmatic evidence from developing countries indicates that integration of
RTIs/STIs prevention and management with existing health services is both feasible
and cost effective. The National Population Policy - 2000 also highlights the need
for programmes, which include provision of RTI/STI and HIV/AIDS prevention,
screening and management in reproductive health care settings. Appropriately
designed, primary prevention and case management interventions would contribute
significantly in reducing the burden of the disease and improving the quality of life.
The last decade is witness to major advances in the programming for RTI/STI
prevention and management interventions. Depending on the magnitude of the
problem and maturity of the programmes, variety of the approaches are being
suggested. The present guide reviews available global and regional experiences and
provides strategic directions, which are likely to be the most effective in addressing
these problems in India.
The need for a concise information on different components of the programmatic
response to meet this challenge has been articulated at several levels. The present
publication is an attempt to fulfill such information gaps, that constitute a major
constraint in designing appropriate interventions. We sincerely hope that programme
managers and service providers will find this information useful. The efforts of
Population Council, South and East Asia Regional Office are appreciated for putting
together evidence based information in this publication.

November 2001

Francois M. Farah
UNFPA Representative
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